Prot# AVF4064g: A Randomized, Blinded, Placebo-Controlled, Multicenter, Phase II Study of Bevacizumab in Combination with Bortezomib in Patients with Relapsed or Refractory Multiple Myeloma

Project: Research project

Project Details

StatusFinished
Effective start/end date1/10/08 → 1/10/11

Funding

  • PRA Health Sciences (AVF4064g)
  • Genentech, Inc. (AVF4064g)
View all
View less